ANXA2
ATC code L01
Abemaciclib
Acalabrutinib
Aclarubicin
Adagrasib (data page)
Adenosine deaminase inhibitor
Adipotide
Afatinib
Aflibercept
Alectinib
Alemtuzumab
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amivantamab
Amrubicin
Amsacrine
Anagrelide
Anaplastic lymphoma kinase
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Anticancer medication
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asciminib
Asparaginase
Asparagine
Atezolizumab
Atezolizumab/hyaluronidase
Atrasentan
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axicabtagene ciloleucel
Axitinib
Azacitidine
Aziridine
BRAF (gene)
Baricitinib
Bcr-abl fusion protein
Belantamab mafodotin
Belinostat
Belotecan
Belzutifan
Bendamustine
Bermekimab
Bevacizumab
Bexarotene
Binimetinib
Bisantrene
Bleomycin
Blinatumomab
Bortezomib
Bosutinib
Breakthrough therapy
Brentuximab vedotin
Brexucabtagene autoleucel
Brigatinib
Bruton's tyrosine kinase
Busulfan
By mouth
C-Met
CAS Registry Number
CD117
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
Cabazitaxel
Cabozantinib
Camptotheca
Camptothecin
Cancer immunotherapy
Capecitabine
Capmatinib
Carboplatin
Carboquone
Carfilzomib
Carmofur
Carmustine
Catumaxomab
Cediranib
Celecoxib
Cell-cycle nonspecific antineoplastic agents
Cemiplimab
Ceritinib
Cetuximab
Chemical formula
Chemotherapy
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
ClinicalTrials.gov
Clinical trial
Clofarabine
Cobimetinib
Colorectal cancer
Committee for Medicinal Products for Human Use
CompTox Chemicals Dashboard
Copanlisib
Cosibelimab
Cositecan
Crisnatol
Crizotinib
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA polymerase inhibitor
DNA replication
Dabrafenib
Dacarbazine
Dacomitinib
Dactinomycin
DailyMed
Dalpiciclib
Daratumumab
Dasatinib
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dicycloplatin
Dihydrofolate reductase inhibitor
Dinutuximab beta
Docetaxel
Dostarlimab
Doxifluridine
Doxorubicin
DrugBank
Drug class
Drug nomenclature
Drugs.com
Durvalumab
Duvelisib
ECHA InfoCard
EML4
Edrecolomab
Efaproxiral
Eflornithine
Elesclomol
Elotuzumab
Elranatamab
Elsamitrucin
Enasidenib
Encorafenib
Endothelin receptor antagonist
Enfortumab vedotin
Entinostat
Entrectinib
Enzyme inhibitor
EpCAM
Epacadostat
Epcoritamab
Epidermal growth factor receptor
Epirubicin
Epothilone
ErbB
Erdafitinib
Eribulin
Erlotinib
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Medicines Agency
Everolimus
Exatecan
Exotoxin
Farnesyltransferase inhibitor
Fast track (FDA)
Fedratinib
Fibroblast growth factor receptor
Filgotinib
Floxuridine
Fludarabine
Fluoropyrimidine
Fluorouracil
Food and Drug Administration
Fotemustine
Fruquintinib
Fusion protein
Futibatinib
Fuzuloparib
Gefitinib
Gemcitabine
Gemtuzumab ozogamicin
Gilteritinib
Gimatecan
Glasdegib
Glofitamab
HER2/neu
Halogenation
Hedgehog signaling pathway
Histone deacetylase inhibitor
Hydrazine
Hydroxycarbamide
Hypomethylating agent
IMP dehydrogenase
IUPAC nomenclature of chemistry
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imatinib
Imetelstat
Inavolisib
Indicated
Infigratinib
Inotuzumab ozogamicin
Intercalation (biochemistry)
Interleukin 2
International Chemical Identifier
Ipilimumab
Irinotecan
Isatuximab
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
Janus kinase
K-Ras(G12C) inhibitor 6
KEGG
KRAS
Lapatinib
Larotaxel
Larotrectinib
Lazertinib
Lenvatinib
Lestaurtinib
Leukemia
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Lomustine
Loncastuximab tesirine
Lonidamine
Lorlatinib
Losoxantrone
Lucanthone
Lung cancer
Lurbinectedin
Lurtotecan
Lymphatic system
Lymphoma
MEN1
MTOR inhibitor
M phase
Mannosulfan
Masitinib
Masoprocol
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Microtubule
Midostaurin
Mirati Therapeutics
Mirvetuximab soravtansine
Mitobronitol
Mitogen-activated protein kinase kinase
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Mobocertinib
Mogamulizumab
Molar mass
Momelotinib
Monoclonal antibody therapy
Mosunetuzumab
Moxetumomab pasudotox
Myeloid
Nadofaragene firadenovec
Navitoclax
Naxitamab
Necitumumab
Nedaplatin
Nelarabine
Neratinib
Nilotinib
Nimustine
Nintedanib
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Nivolumab
Non-receptor tyrosine kinase
Non-small cell lung cancer
Obecabtagene autoleucel
Obinutuzumab
Oblimersen
Odronextamab
Ofatumumab
Olaparib
Olaratumab
Olmutinib
Olutasidenib
Omacetaxine mepesuccinate
Oportuzumab monatox
Oprozomib
Orelabrutinib
Orphan drug
Ortataxel
Osimertinib
Oxaliplatin
PARP inhibitor
Paclitaxel
Pacritinib
Padeliporfin
Palbociclib
Panitumumab
Panobinostat
Parsaclisib
Pazopanib
Pegaspargase
Pembrolizumab
Pemetrexed
Pemigatinib
Pentostatin
Pertuzumab
Pexidartinib
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pi3K inhibitor
Pipobroman
Pirarubicin
Pirtobrutinib
Pixantrone
Platelet-derived growth factor receptor
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Polatuzumab vedotin
Ponatinib
Porfimer sodium
Porphyrin
Pralatrexate
Pralsetinib
Prednimustine
Prescription drug
Proapoptotic
Procarbazine
Prohibitin
Prolgolimab
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Public domain
Purine analogue
Pyrimidine analogue
Quizartinib
RET proto-oncogene
RTK class III
Rabacfosadine
Radotinib
Raltitrexed
Ramucirumab
Ranimustine
Receptor antagonist
Receptor tyrosine kinase
Regorafenib
Regulation of therapeutic goods
Repotrectinib
Retifanlimab
Retinoid
Retinoid X receptor
Revumenib
Ribociclib
Ribonucleotide reductase inhibitor
Ridaforolimus
Ripretinib
Rituximab
Rociletinib
Romidepsin
Route of administration
Rubitecan
Rucaparib
Ruxolitinib
S phase
Sabatolimab
Sacituzumab govitecan
Satraplatin
Seliciclib
Selinexor
Selpercatinib
Selumetinib
Semaxanib
Semustine
Serplulimab
Sex steroid
Silatecan
Simplified molecular-input line-entry system
Sirolimus
Sitimagene ceradenovec
Sonidegib
Sorafenib
Sotorasib
Spindle poison
Src (gene)
Streptomyces
Streptozotocin
Sugemalimab
Sunitinib
Tabelecleucel
Tafasitamab
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Talquetamab
Targeted cancer therapy
Tarlatamab
Taxane
Tazemetostat
Tebentafusp
Teclistamab
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Temsirolimus
Teniposide
Tepotinib
Tesetaxel
Testolactone
Thiopurine
Thiotepa
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Tislelizumab
Tisotumab vedotin
Tivozanib
Toceranib
Topoisomerase inhibitor
Topotecan
Toripalimab
Tositumomab
Trabectedin
Trametinib
Trastuzumab
Trastuzumab/hyaluronidase
Trastuzumab deruxtecan
Trastuzumab emtansine
Tremelimumab
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trilaciclib
Trofosfamide
Tucatinib
Type II topoisomerase
Type I topoisomerase
Tyrosine kinase inhibitor
Umbralisib
Unique Ingredient Identifier
Uramustine
VEGF receptors
Valrubicin
Vandetanib
Vascular endothelial growth factor